Aiming for a $75 million initial fund closing, the new venture investor plans to connect startups with nonprofits to speed their research.
Source link
Vie Ventures Launches to Bankroll Autoimmune-Disease Biotechs
Related Posts
iPhone drove Apple’s robust earnings — but investors weren’t too enthused
A common view of the Apple retail retailer on Nanjing East Highway in Shanghai, China, on Jan. 29, 2026. Ying…
Eli Lilly to Buy Biotech Orna Therapeutics for Up to $2.4 Billion
Eli Lilly has struck a deal to purchase genetic-medicine biotechnology firm Orna Therapeutics for as much as $2.4 billion in…
Why senator says US should spy more on China’s companies
Return a decade and most People had by no means heard of Huawei. In the present day, the Chinese language…